mln0264
mAbexperimentalADC
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2012 (NCT01577758)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
- Multi-specific
- No
- Payload
- Monomethylauristatin E
Oral
No
Parenteral
No
Topical
No
Also known as
- mln0264
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02391038 | Phase 1 | Dec 1, 2014 | Millennium Pharmaceuticals |
| NCT02202759 | Phase 2 | Aug 4, 2014 | Millennium Pharmaceuticals |
| NCT02202785 | Phase 2 | Jul 2, 2014 | Millennium Pharmaceuticals |
| NCT01577758 | Phase 1 | Jun 1, 2012 | Millennium Pharmaceuticals |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Millennium Pharmaceuticals | For profit | 4 | 4 | 2 | 2012 |
1 organizations
Page 1 / 1